Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Günter Silbernagl"'
Autor:
Heiko Ilchmann, Nathaly Samy, Daniela Reichhardt, Darja Schmidt, Jacqueline D Powell, Thomas P H Meyer, Günter Silbernagl, Rick Nichols, Heinz Weidenthaler, Laurence De Moerlooze, Liddy Chen, Paul Chaplin
Publikováno v:
The Journal of Infectious Diseases. 227:1203-1213
Background Although modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed. Methods Participants naive to smallpox vaccination
Autor:
Elke Jordan, Golam Kabir, Stephanie Schultz, Günter Silbernagl, Darja Schmidt, Victoria A Jenkins, Heinz Weidenthaler, Daria Stroukova, Barbara K Martin, Laurence De Moerlooze
Publikováno v:
The Journal of Infectious Diseases.
Background Respiratory syncytial virus (RSV) causes significant disease burden in older adults. MVA-BN-RSV is a novel poxvirus-vectored vaccine encoding internal and external RSV proteins. Methods In a phase 2a randomized double-blind, placebo-contro
Autor:
Elke Jordan, Golam Kabir, Stephanie Schultz, Günter Silbernagl, Darja Schmidt, Victoria A. Jenkins, Heinz Weidenthaler, Daria Stroukova, Barbara K. Martin, Laurence De Moerlooze
BackgroundRespiratory syncytial virus (RSV) causes significant disease burden in infants and older adults. Most vaccines in development focus on the virus’s F protein. MVA-BN-RSV is a novel vectored vaccine encoding internal and external proteins f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4b0805f60abee5ea9fb8570fc861c04
https://doi.org/10.1101/2022.12.02.22283030
https://doi.org/10.1101/2022.12.02.22283030
Autor:
Heinz Weidenthaler, Florian Lienert, Daniela Reichhardt, Darja Schmidt, Günter Silbernagl, Thomas Meyer, Paul Chaplin
Publikováno v:
Open Forum Infectious Diseases. 9
Background The ongoing monkeypox outbreak, a WHO-declared PHEIC, requires fast and broad rollout of MVA-BN vaccinations among risk groups. An initial single-dose strategy, followed by a delayed second dose beyond the approved 4-week interval, could h
Autor:
Heiko, Ilchmann, Nathaly, Samy, Daniela, Reichhardt, Darja, Schmidt, Jacqueline D, Powell, Thomas Ph, Meyer, Günter, Silbernagl, Rick, Nichols, Heinz, Weidenthaler, Laurence, De Moerlooze, Liddy, Chen, Paul, Chaplin
Publikováno v:
The Journal of infectious diseases.
Though Modified Vaccinia Ankara - Bavarian Nordic (MVA-BN®). vaccination is approved for smallpox and monkeypox prevention, immunological persistence and booster effects remain undescribed.Participants naïve to smallpox vaccination were randomized
Autor:
Günter Silbernagl, Katrin Nopora, Paul Chaplin, Steven J. Lawrence, Edgar T. Overton, Heinz Weidenthaler, Darja Schmidt, Brigitte Koenen, Jack T. Stapleton
Publikováno v:
Vaccine. 38:2600-2607
Traditional replicating smallpox vaccines are associated with serious safety concerns in the general population and are contraindicated in immunocompromised individuals. However, this very population remains at greatest risk for severe complications
Autor:
Heinz Weidenthaler, Günter Silbernagl, Paul Chaplin, Joachim Hornung, Jane Maclennan, Christopher R. Heery, HeeChoon S. Lee, Matthew Hahn, Craig D. Koca, Phillip R. Pittman, Nathaly Samy, Thomas Meyer, Darja Schmidt
Publikováno v:
The New England journal of medicine. 381(20)
Many countries have stockpiled vaccines because of concerns about the reemergence of smallpox. Traditional smallpox vaccines are based on replicating vaccinia viruses; these vaccines have considerable side effects.To evaluate the efficacy of modified
Autor:
Günter Silbernagl, Paul Chaplin, Heinz Weidenthaler, Tatiana Adams, Darja Schmidt, Elke Jordan, Liddy M Chen, Daria Stroukova, Thomas Ph Meyer, Daniela Reichhardt, Sanja Vidojkovic, Sonja De Carli, Nathaly Samy
Publikováno v:
Vaccine. 38(11)
Respiratory disease caused by RSV infection is recognized as a severe public health issue in infants, young children and elderly with no specific treatment option. Vaccination may be the most effective strategy to combat this highly infectious virus